Yu.V. Embutnieks (1), I.N. Voynovan (1), S.V. Kolbasnikov (2), D.S. Bordin (1, 2)
AUTOIMMUNE GASTRITIS: PATHOGENESIS, MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
|
8-14 |
I.A. Oganezova, E.B. Avalueva
HELICOBACTER PYLORI-NEGATIVE PEPTIC ULCER DISEASE: HISTORICAL FACTS AND MODERN REALITIES
|
16-20 |
E.V. Skazyvaeva, E.B. Avalueva, S.I. Sitkin, I.G. Bakulin, M.I. Skalinskaya
DIVERTICULAR DISEASE OF THE COLON
|
22-30 |
Yu.G. Sandler (1), A.V. Polukhina (1), E.V. Vinnitskaya (1), I.G. Bakulin (2), Zh.V. Borunova (1), V.A. Keyyan (1)
PROGNOSTIC SIGNIFICANSE OF THE POLYMORPHISM OF GENES ASSOCIATED WITH THE RISK OF TYPE 2 DIABETES MELLITUS AND OBESITY, FOR THE DEVELOPMENT OF LIVER FIBROSIS AND HEPATIC STEATHOSIS IN PATIENTS WITH NON-ALCOHOLIC FAT LIVER DISEASE
|
31-36 |
I.G. Pakhomova (1), I.V. Gubonina (2)
NSAID-INDUCED PATHOLOGY OF THE GASTROINTESTINAL TRACT: WHAT IS REMAINING IN THE SHADOW?
|
37-43 |
I.G. Bakulin, L.N. Belousova
BARRETT’S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: A NEW LOOK AT THE PROBLEM
|
44-46 |
E.V. Vinnitskaya (1), Yu.G. Sandler (1), D.T. Abdurakhmanov (2), I.G. Bakulin (3), E.A. Belousova (8), A.O. Buyeverov (2), E.Z. Burnevich (2), R.B. Gudkova (1), M.G. Efanov (1), E.Yu. Eremina (9), Т.М. Ignatova (2), L.Yu. Ilchenko (6), Т.N. Lopatkina (2), I.G. Nikitin (6), M.S. Navruzbekov (5), A.I. Parfenov (1), A.I. Pavlov (10), A.S. Potapov (2), S.D. Podymova (1), K.L. Raykhelson (4), A.R. Reyzis (11), D.L. Rotin (1), R.G. Sayfutdinov (7), V.L. Syutkin (5), Т.V. Strokova (2), S.G. Khomeriki (1), T.Yu. Khaymenova (1)
MAIN PROVISIONS OF THE RUSSIAN CONSENSUS ON DIAGNOSIS AND TREATMENT OF AUTOIMMUNE HEPATITIS
|
47-55 |
I.G. Bakulin, T.N. Zhigalova, E.V. Skazyvaeva, M.I. Skalinskaya, S.I. Sitkin, E.A. Popova
EXPERIENCE OF INTRODUCTION OF THE FEDERAL REGISTRY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN SAINT PETERSBURG
|
56-59 |
I.A. Oganezova (1, 2), O.I. Medvedeva (1), E.V. Skazyvaeva (1), N.V. Smirnova (2), L.E. Alekseeva (2)
IRRITABLE BOWEL SYNDROME: DIAGNOSIS – “MASK” OF INTESTINAL ABNORMAL DEVELOPMENT
|
60-64 |
V.I. Simanenkov, N.V. Bakulina, Т.S. Fil, A.Kh. Khubieva
EVALUATION OF EFFICIENCY OF H. PYLORI ERADICATION IN CASE OF ADDITION OF CYTOPROTECTIVE PREPARATION REBAMIPIDE TO THE TREATMENT: RESULTS OF THE BASTION TRIAL
|
65-71 |
E.V. Borodulina, I.V. Mareyev, M.Yu. Kolokoltsova, I.A. Samykina, V.V. Udut
COMPARATIVE EFFICIENCY OF NEOBUTINE® RETARD, FILM-COATED PROLONGED-RELEASE TABLETS 300 MG, AND TRIMEDAT®, TABLETS 200MG, IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
|
72-77 |
I.G. Bakulin, L.N. Belousova, L.S. Evdokimova
IS THROMBOCYTOPENIA ALWAYS THE PROBLEM OF THE HEMATOLOGIST? DIAGNOSTIC AND THERAPEUTIC ALGORITHMS IN PRACTICE OF THERAPIST AND GASTROENTEROLOGIST
|
78-84 |
M.I. Skalinskaya (1), I.G. Bakulin (1), E.V. Skazyvaeva (1), Т.N. Zhigalova (1), K.N. Ryndin (1), M.V. Solovyev (2)
BIOLOGICAL PREPARATIONS IN THERAPY OF INFLAMMATORY BOWEL DISEASES: REALITY AND PROSPECTS
|
85-93 |
L.S. Oreshko, I.G. Bakulin, O.Yu. Chizhova, M.S. Zhuravleva, E.A. Semenova, E.Yu. Pavlova, Z.M. Tskhovrebova
DIFFICULTIES IN DIAGNOSIS OF CELIAC DISEASE IN ADULTS
|
94-99 |
N.B. Voloshina (1), Yu.Yu. Venzhina (2), N.L. Kazakova (2), I.O. Voloshina (3)
HEREDITARY HEMOCHROMATOSIS (CASE REPORT)
|
100-103 |